Compare NXL & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NXL | OXBR |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | Cayman Islands |
| Employees | N/A | 4 |
| Industry | Medical Specialities | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 7.7M |
| IPO Year | 2022 | 2014 |
| Metric | NXL | OXBR |
|---|---|---|
| Price | $1.87 | $0.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 16.6K |
| Earning Date | 11-13-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.76 | 37.78 |
| EPS | N/A | ★ 0.02 |
| Revenue | $301,647.00 | ★ $2,577,000.00 |
| Revenue This Year | $14.37 | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | ★ N/A | $49.99 |
| Revenue Growth | 78.78 | ★ 371.98 |
| 52 Week Low | $0.22 | $0.66 |
| 52 Week High | $99.00 | $1.86 |
| Indicator | NXL | OXBR |
|---|---|---|
| Relative Strength Index (RSI) | 30.65 | 39.03 |
| Support Level | $0.22 | $0.93 |
| Resistance Level | $5.36 | $0.98 |
| Average True Range (ATR) | 0.43 | 0.12 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 1.35 | 9.07 |
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
Oxbridge Re Holdings Ltd is a holding company operating complementary growth platforms across AI infrastructure and digital financial infrastructure. Through AI GridWorks, the Company is focused on developing, owning, and operating AI data centers and related infrastructure. Through SurancePlus and its reinsurance subsidiaries, Oxbridge provides tokenized real-world asset (RWA) securities and reinsurance solutions, including tokenized reinsurance offerings utilizing blockchain technology.